The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-{2-[2-Hydroxy-3-(4-hydroxy-4-phenyl-piperidin-1-yl)-propoxy]-phenyl}-3-naphthalen-1-yl-propan-1-one ID: ALA147055
PubChem CID: 9983792
Max Phase: Preclinical
Molecular Formula: C33H35NO4
Molecular Weight: 509.65
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCc1cccc2ccccc12)c1ccccc1OCC(O)CN1CCC(O)(c2ccccc2)CC1
Standard InChI: InChI=1S/C33H35NO4/c35-28(23-34-21-19-33(37,20-22-34)27-12-2-1-3-13-27)24-38-32-16-7-6-15-30(32)31(36)18-17-26-11-8-10-25-9-4-5-14-29(25)26/h1-16,28,35,37H,17-24H2
Standard InChI Key: NVSXFDQTCYVKHH-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
7.4000 0.3708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4042 -1.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9750 -0.4500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1167 -2.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4000 -0.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6875 0.7833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4042 -0.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5542 -4.5875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1167 -0.4625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8375 -4.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8042 1.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1167 -2.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8292 -1.7042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8375 -3.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9667 0.3708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6875 -0.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2625 -0.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5542 -5.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 -0.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8292 -0.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1125 -0.0417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 0.3708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6875 -2.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1292 -5.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1250 -4.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2542 -4.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8417 -5.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6875 -0.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6292 1.0958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3917 1.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2667 -5.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9750 -1.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9667 -4.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0417 1.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7917 2.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9750 -0.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9792 -5.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6167 2.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 7 1 0
3 15 1 0
4 2 1 0
5 1 1 0
6 1 1 0
7 9 1 0
8 10 1 0
9 20 1 0
10 14 1 0
11 1 1 0
12 4 1 0
13 4 2 0
14 12 1 0
15 6 1 0
16 5 1 0
17 3 1 0
18 8 1 0
19 17 1 0
20 19 1 0
21 1 1 0
22 19 1 0
23 2 2 0
24 25 1 0
25 10 2 0
26 8 2 0
27 24 2 0
28 7 2 0
29 11 2 0
30 11 1 0
31 18 2 0
32 36 2 0
33 26 1 0
34 29 1 0
35 30 2 0
36 28 1 0
37 33 2 0
38 35 1 0
16 3 1 0
38 34 2 0
32 23 1 0
18 27 1 0
37 31 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 509.65Molecular Weight (Monoisotopic): 509.2566AlogP: 5.38#Rotatable Bonds: 10Polar Surface Area: 70.00Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.74CX Basic pKa: 7.43CX LogP: 5.00CX LogD: 4.68Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.28Np Likeness Score: -0.44
References 1. Fleischer R, Wiese M.. (2003) Three-dimensional quantitative structure-activity relationship analysis of propafenone-type multidrug resistance modulators: influence of variable selection on test set predictivity., 46 (23): [PMID:14584949 ] [10.1021/jm030876r ] 2. Kaiser D, Terfloth L, Kopp S, Schulz J, de Laet R, Chiba P, Ecker GF, Gasteiger J.. (2007) Self-organizing maps for identification of new inhibitors of P-glycoprotein., 50 (7): [PMID:17352460 ] [10.1021/jm060604z ]